Suppression of tumorigenicity 8 (ovarian)
An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it. |
 | This article includes a list of references, related reading, or external links, but its sources remain unclear because it lacks inline citations. (July 2018) |
Suppression of tumorigenicity 8 (ovarian) is a protein that in humans is encoded by the ST8 gene. This gene is located on a 300-kb segment of chromosome 6q25-27, which facilitates further efforts to identify a gene associated with ovarian cancer. The official symbol (ST8) and official name "Suppression of Tumorigenicity 8" are maintained by the HGNC. It is also known as Oncogene OVC (ovarian adenocarcinoma oncogene).
The inactivation of the tumor suppressor gene in ST8 may be crucial for the development of cancer; the homologous regions in humans is the short arm of chromosome 6 for deletions in sporadic ovarian adenocarcinomas. In 91 informative sporadic tumors, 34 lost their heterozygosity, including some benign, low-malignancy potential, and early stage tumors, suggesting that it is an early event in the development of ovarian adenocarcinoma. In different portions of chromosome 6q, there were deletions and translocations which were subsequently reported by cytogenic analyses of primary ovarian carcinomas and ovarian cancer cell lines.
References
[edit]- ST8 suppression of tumorigenicity 8 (ovarian) [ Homo sapiens (human)
- Am J Hum Genet. 1994 Jul;55(1):143-9
- Buick et al., 1985; Deger et al., 1997; Sheer et al., 1987; Tibiletti et al., 1996; Trent and Salmon, 1981;Whang-Peng et al., 1984
https://www.ncbi.nlm.nih.gov/gene/6765
 | This article on a gene on human chromosome 6 is a stub. You can help Wikipedia by expanding it. |